Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Trump’s Maduro takedown resets the global chessboard and...
GORDON SONDLAND: Trump’s realpolitik may be the only...
Israel shuts door on Turkey in Gaza as...
Trump warns ‘sick’ South American leader, reiterates ‘we...
Cuba’s shadow in Venezuela: Havana’s intelligence and military...
Democrats label Trump’s Venezuela operation an ‘impeachable offense’
Trump signs ‘Make Iran Great Again’ hat alongside...
Lawmakers rip Biden after Trump-Maduro taunt resurfaces –...
Congress rolls out $174B spending bill as Jan...
3 key takeaways from Trump’s push to put...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Business

DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

by admin January 19, 2025
January 19, 2025
DOJ sues Walgreens, alleging it ‘knowingly’ filled millions of invalid prescriptions

The Department of Justice said Friday that it sued pharmacy giant Walgreens over allegedly dispensing millions of unlawful prescriptions.

The DOJ said that Walgreens from August 2012 until the present “knowingly” filled those prescriptions, which “lacked a legitimate medical purpose, were not valid, and/or were not issued in the usual course of professional practice.” 

“This lawsuit seeks to hold Walgreens accountable for the many years that it failed to meet its obligations when dispensing dangerous opioids and other drugs,” said Principal Deputy Assistant Attorney General Brian Boynton, head of the DOJ’s Civil Division.

Boynton said that Walgreens pharmacists filled millions of prescriptions with “clear red flags that indicated the prescriptions were highly likely to be unlawful.”

The company “systematically pressured its pharmacists to fill prescriptions, including controlled substance prescriptions, without taking the time needed to confirm their validity,” Boynton said. “These practices allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores.”

Some Walgreens patients died of overdose deaths shortly after getting invalid prescriptions filled at Walgreens, the DOJ alleges.

The 300-page lawsuit was filed Thursday in U.S. District Court in Chicago.

Walgreens in a statement said, “We are asking the court to clarify the responsibilities of pharmacies and pharmacists and to protect against the government’s attempt to enforce arbitrary ‘rules’ that do not appear in any law or regulation and never went through any official rulemaking process.”

“We will not stand by and allow the government to put our pharmacists in a no-win situation, trying to comply with ‘rules’ that simply do not exist,” Walgreens said.

“Walgreens stands behind our pharmacists, dedicated healthcare professionals who live in the communities they serve, filling legitimate prescriptions for FDA-approved medications written by DEA-licensed prescribers in accordance with all applicable laws and regulations.”

The suit alleges that although Walgreens issued written policies that reflected its understanding of legal obligations, the company took other actions which it knew prevented its pharmacists from complying with them.

“Walgreens prioritized profits over safety and compliance by implementing policies and practices that required pharmacists to fill prescriptions quickly and left pharmacists without enough time or resources to exercise their corresponding responsibility,” the suit said.

“One such metric was ‘Verify By Promise Time’ (VBPT), which expected a pharmacist to fill a prescription within 15 minutes for a ‘waiter’ (a customer waiting in the pharmacy store for the prescription),” the suit alleges.

“Walgreens also tracked pharmacists that dispensed a low rate of controlled substances through its ‘Non-dispensing Pharmacist Report,’” the suit said.

“Walgreens created this metric in part because it believed pharmacists who refused to fill controlled-substance prescriptions compromised Walgreens’s customer service.”

This post appeared first on NBC NEWS

previous post
Obama wishes wife Michelle happy birthday as she stays away from key public events
next post
Tech 5: Trump to Prioritize Crypto, Biden Blocks AI Chip Exports

You may also like

Spanish retailer Mango to open 60 new U.S....

November 27, 2024

UPS is ‘disposing of’ U.S.-bound packages over customs...

October 13, 2025

Google employees pressure costumed execs at all-hands meeting...

November 2, 2024

Getty Images to buy Shutterstock as part of...

January 9, 2025

Nvidia passes Apple as world’s most valuable company

November 8, 2024

Boeing starts furloughing tens of thousands of employees...

September 19, 2024

Eli Manning says ‘only one team’ he’d take...

January 8, 2025

Boeing delivers most airplanes since late 2023 after...

July 9, 2025

Fed Chair Powell says ‘time has come’ for...

August 25, 2024

SEC charges Robinhood with securities violations; brokerage to...

January 14, 2025

Recent Posts

  • Trump’s Maduro takedown resets the global chessboard and reasserts American power
  • GORDON SONDLAND: Trump’s realpolitik may be the only way to end the Ukraine war
  • Israel shuts door on Turkey in Gaza as Trump praises Erdogan, plays down clash
  • Trump warns ‘sick’ South American leader, reiterates ‘we need Greenland’ for national security
  • Cuba’s shadow in Venezuela: Havana’s intelligence and military ties exposed after Maduro raid

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (964)
    • Investing (3,796)
    • Politics (4,591)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.